Que et al. have recently carried out a meta-analysis identifying PTEN loss as a prognostic factor for worse overall survival (OS) in patients affected with kidney cancer due its role in increasing aggressiveness and the progression of this type of tumor [78]. Here, PTEN is linked to neoplasm.